Pacira reported 23.09 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Astellas Pharma 9.35 41.1 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 19.02 9.62 Jun/2025
Ligand Pharmaceuticals 43.03 4.09 Mar/2025
Novo Nordisk 17.47 3.29 Jun/2025
Pacira 23.09 5.46 Jun/2025
Perrigo 49.7 2.52K Jun/2025
Pfizer 9.12 8.86 Jun/2025
Supernus Pharmaceuticals 22.02 2.92 Jun/2025
Teva Pharmaceutical Industries 9.72 15.14 Jun/2025
Zoetis 25.94 2.65 Jun/2025